Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Equity Average (2016 - 2025)

STRATA Skin Sciences' Equity Average history spans 14 years, with the latest figure at $2.1 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 70.63% to $2.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 70.63% decrease, with the full-year FY2025 number at $3.9 million, down 55.38% from a year prior.
  • Equity Average hit $2.1 million in Q4 2025 for STRATA Skin Sciences, up from $923000.0 in the prior quarter.
  • Over the last five years, Equity Average for SSKN hit a ceiling of $26.0 million in Q3 2021 and a floor of $923000.0 in Q3 2025.
  • Historically, Equity Average has averaged $15.4 million across 5 years, with a median of $17.3 million in 2023.
  • Biggest five-year swings in Equity Average: dropped 0.43% in 2021 and later tumbled 90.24% in 2025.
  • Tracing SSKN's Equity Average over 5 years: stood at $25.8 million in 2021, then decreased by 15.44% to $21.8 million in 2022, then tumbled by 33.81% to $14.4 million in 2023, then tumbled by 50.23% to $7.2 million in 2024, then plummeted by 70.63% to $2.1 million in 2025.
  • Business Quant data shows Equity Average for SSKN at $2.1 million in Q4 2025, $923000.0 in Q3 2025, and $1.8 million in Q2 2025.